Modern approaches to the treatment of patients with skin mycosis

Fungal diseases are one of the urgent medical and social problems that need to be solved and to seek different methods of treatment. The work demonstrates the use of antimycotic external exposure “Bifonazol”. A success­ful evaluation of microbiological and clinical studies in 39 patients has been performed. The main pathogens of superficial mycotic skin lesions are characterized by high sensitivity to the drug, manifested with relatively large growth retardation diameters of their cultures (> 25 mm) when tested in vitro. As a result of observation of pa­tients, who used bifonazole, complete clinical and labo­ratory healing was established for 28 days of treatment in 100% of cases. In turn, the drug has a minimal abortion system, which helps to avoid side effects on the body.